Pulse Biosciences, Inc.
USD24.28
-0.39 (-1.58%)
CEO
Paul Arthur LaViolette
IPO Date
2016-05-18
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Country
US
Open
$24.45
Prev. Close
$24.67
Day Low
$23.60
Day High
$24.75
52W Low
$12.56
52W High
$27.98
Market Cap
$1.68B
Volume
0.23M
| 15,000 |
| $19.69 |
| 11 May 2026 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | P-Purchase | Acquired | 15,000 | $19.69 |
| 11 May 2026 | DUGGAN ROBERT W | director, 10 percent owner: | P-Purchase | Acquired | 660,233 | $19.69 |
| 3 Apr 2026 | UECKER DARRIN | director, officer: Chief Technology Officer | A-Award | Acquired | 100,000 | $0.00 |
| 23 Feb 2026 | Danahy Kevin Patrick | Chief Commercial Officer | M-Exempt | Acquired | 5,000 | $1.53 |
| 23 Feb 2026 | Danahy Kevin Patrick | Chief Commercial Officer | M-Exempt | Disposed | 5,000 | $1.53 |
| 23 Feb 2026 | Danahy Kevin Patrick | Chief Commercial Officer | S-Sale | Disposed | 5,000 | $23.64 |
| 17 Feb 2026 | Danahy Kevin Patrick | Chief Commercial Officer | M-Exempt | Acquired | 20,000 | $1.53 |
| 17 Feb 2026 | Danahy Kevin Patrick | Chief Commercial Officer | S-Sale | Disposed | 20,000 | $23.37 |